Patient acceptance of non-invasive testing for fetal aneuploidy via cell-free fetal DNA

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 1, 2014, Pages 106-109

  Vahanian, Sevan A ^a   Baraa Allaf, M ^a   Yeh, Corinne ^a   Chavez, Martin R ^a   Kinzler, Wendy L ^a   Vintzileos, Anthony M ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antepartum; Noninvasive prenatal testing; Obstetrics; Prenatal testing

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; DNA DETERMINATION; FEMALE; HEALTH INSURANCE; HUMAN; NON INVASIVE PROCEDURE; PATIENT ATTITUDE; PRENATAL SCREENING; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ADULT; COHORT STUDIES; DNA; FEMALE; GENETIC TESTING; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INSURANCE, HEALTH; MATERNAL-FETAL EXCHANGE; MEDICAID; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PREFERRED PROVIDER ORGANIZATIONS; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; TRISOMY; UNITED STATES;

EID: 84889638841     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.806477     Document Type: Article

References (11)

1. Lo YMD, Lo ES, Watson N, et al. Two-way cell traffic between mother and fetus: Biologic and clinical implications. Blood 1996; 88:4390-5
2. Bischoff FZ, Lewis DE, Simpson JL. Cell-free fetal DNA in maternal blood: Kinetics, source and structure. Human Reproduction Update. 2004 November;11:59-67
3. Lo YMD, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Gen 1999;64: 218-24
4. Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reproduction Update. 2009 October;15:139-51
5. Rijnders RJ, Christiaens GC, Bossers B, et al. Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol 2004; 103:157-64
6. Chetty S, Garabedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013. [Epub ahead of print]. doi:10.1002/ pd.4125
7. Fairbrother G, Johnson S, Musci TJ, et al. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat Diagn 2013;15:1-5
8. Allyse MA, Sayres LC, Havard M, et al. Best ethical practices for clinicians and laboratories in the provision of non-invasive prenatal testing. Prenat Diagn 2013. [Epub ahead of print]. doi:10. 1002/pd. 4144
9. Vergani P, Locatelli A, Biffi A, et al. Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older. Prenatal Diagn 2002;22:769-74
10. Vintzileos AM, Guzman ER, Smulian JC, et al. Choice of second-Trimester genetic sonogram for detection of trisomy 21. Obstet Gynecol 1997;90:187-90
11. ACOG Committee Opinion Number 545: Noninvasive Prenatal Testing for Fetal Aneuploidy. Obstet Gynecol. 2012;120:1532-4.